Atom Investors’s Usana Health Sciences USNA Stock Holding History

Atom Investors’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-12,549	Closed	-$1.48M	–	717
2018 Q4	$1.48M	Buy	+12,549	New	+$1.45M	0.15%	185

Other funds holding USNA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

JIM

Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Atom Investors's USNA Position: Q1 2019 in Review

Atom Investors sold out of Usana Health Sciences (USNA) in Q1 2019, closing a stake of 12,549 shares — an estimated $1.48M sold.

Atom Investors first reported a position in USNA in Q4 2018 and held it in 1 quarter. The position peaked at $1.48M in Q4 2018. 188 funds tracked by Wall St. Rank hold USNA as of Q1 2019.

Atom Investors reported no remaining Usana Health Sciences position as of Q1 2019 after selling out during the quarter.
Atom Investors sold 12,549 Usana Health Sciences shares in Q1 2019, an estimated $1.48M.
Atom Investors first reported a position in Usana Health Sciences in Q4 2018 and held it in 1 quarter.
Atom Investors's Usana Health Sciences position peaked at $1.48M in Q4 2018.
188 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2019.

Based on Atom Investors's 13F filing for Q1 2019, filed 15 May 2019.